Polar Asset Management Partners Inc. Haemonetics Corp Transaction History

Polar Asset Management Partners Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $3.51 Million - $5.28 Million	-70,800 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $4.08 Million - $5 Million	70,800 New	70,800 $5 Million
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $1.29 Million - $2.95 Million	-24,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $2.76 Million - $3.47 Million	24,900 New	24,900 $2.76 Million
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $2.66 Million - $3.6 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$75.65 - $93.58 $12.1 Million - $15 Million	-160,000 Reduced 84.21%	30,000 $2.62 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $12.3 Million - $17.2 Million	145,000 Added 322.22%	190,000 $17 Million
Q1 2020 May 15, 2020	BUY	$74.34 - $121.82 $3.35 Million - $5.48 Million	45,000 New	45,000 $4.49 Million

348

55.7M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.53B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.